Table 1 Patient and tumour characteristics, treatment details
Characteristic | N (%) |
|---|---|
Gender | |
Male | 42 (18) |
Female | 189 (82) |
Age (years) | |
Median (range) | 44 (9–89) |
Pathology | |
Papillary | 140 (60.6) |
Follicular | 90 (38.9) |
Poorly differentiated | 1 (0.5) |
Tumour size | |
≤ 1 cm | 42 (18.2) |
1–4 cm | 105 (45.5) |
> 4 cm | 56 (24.2) |
Unknown | 28 (12.1) |
T stage | |
pTX | 20 (8.7) |
pT0 | 1 (0.4) |
pT1 | 53 (22.9) |
pT2 | 79 (34.2) |
pT3 | 53 (22.9) |
pT4 | 25 (10.8) |
Nodal status | |
N0 | 147 (63.7) |
N1 | 65 (28.1) |
Unknown | 19 (8.2) |
Metastases | |
M0 | 203 (88) |
M1 | 23 (10) |
Unknown | 5 (2) |
Post-operative risk stratification for risk of recurrence (British Thyroid Association Guidelines 2014) [10] | |
High | 44 (19.1) |
Intermediate | 98 (42.4) |
Low | 82 (35.5) |
Unknown | 7 (3) |
Surgery | |
Nil | 9 (4) |
Lobectomy | 31 (13) |
Total thyroidectomy | 161 (70) |
Total thyroidectomy and neck dissection | 30 (13) |
131Iodine | |
Nil | 60 (26) |
Ablation | 171 (74) |
131Iodine repeated | 60 (26) |
External beam radiation | |
Neck, 56–66 Gy | 9 (4) |
Palliative | 17 (7) |
Nil | 205 (89) |
Recurrence | |
Locoregional | 21 (9.5) |
Distant | 2 (0.9) |
Locoregional and distant | 5 (2.2) |
None | 203 (88) |
Deaths | |
Total number of deaths | 27 (11.6) |
Deaths due to thyroid cancer | 16 (6.9) |